Baird Financial Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,270
Closed -$140K 1743
2022
Q3
$140K Sell
16,270
-134
-0.8% -$1.33K ﹤0.01% 1646
2022
Q2
$134K Buy
16,404
+111
+0.7% +$1.06K ﹤0.01% 1730
2022
Q1
$198K Sell
16,293
-465
-3% -$9.79K ﹤0.01% 1755
2021
Q4
$571K Buy
16,758
+2,701
+19% +$106K ﹤0.01% 1419
2021
Q3
$678K Buy
14,057
+245
+2% +$11.3K ﹤0.01% 1354
2021
Q2
$624K Buy
13,812
+457
+3% +$20.2K ﹤0.01% 1342
2021
Q1
$644K Sell
13,355
-454
-3% -$23.6K ﹤0.01% 1285
2020
Q4
$743K Sell
13,809
-310
-2% -$14K ﹤0.01% 1117
2020
Q3
$521K Sell
14,119
-4,162
-23% -$155K ﹤0.01% 1140
2020
Q2
$566K Buy
18,281
+7,159
+64% +$198K ﹤0.01% 1115
2020
Q1
$307K Sell
11,122
-36
-0.3% -$1.08K ﹤0.01% 1204
2019
Q4
$326K Buy
11,158
+140
+1% +$3.33K ﹤0.01% 1296
2019
Q3
$211K Buy
11,018
+265
+2% +$6.22K ﹤0.01% 1429
2019
Q2
$236K Buy
+10,753
New +$236K ﹤0.01% 1415

Other funds holding NEO

Baird Financial Group's NEO Position: Q4 2022 in Review

Baird Financial Group sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 16,270 shares — an estimated $140K sold.

Baird Financial Group first reported a position in NEO in Q2 2019 and held it in 14 quarters. The position peaked at $743K in Q4 2020. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

  • Baird Financial Group reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
  • Baird Financial Group sold 16,270 NeoGenomics shares in Q4 2022, an estimated $140K.
  • Baird Financial Group first reported a position in NeoGenomics in Q2 2019 and held it in 14 quarters.
  • Baird Financial Group's NeoGenomics position peaked at $743K in Q4 2020.
  • 242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on Baird Financial Group's 13F filing for Q4 2022, filed 13 Feb 2023.